Slide 1Good Distribution Practices: What do they mean to you? Presented by: Hedley Rees, Biotech PharmaFlow, UK Slide 2 Agenda Distribution in Pharmaceuticals Why has GDP…

1. Presentation to Pharmacy IM&T Strategy GroupStrategy Group by the Aegate team 14th July 2014 2. Agenda 1. About Aegate 2. Falsified Medicines Directive2. Falsified…

Illicit Trade in Counterfeit Medicine Dr. Kristina M. Lybecker Department of Economics & Business The Colorado College March 30, 2015 2 Roadmap  Motivation  Definition…

1. Romanian Leading Software Provider for the Healthcare Sector 2. OUR HISTORY • 25 years of software development experience • 20 years ago we started our construction…

Slide 1Life Sciences Life Sciences Industry Trends and Update Bart Reitter, Director of Marketing – Life Sciences QAD West Coast User Group November 2014 Slide 2 Life Sciences…

Slide 1 Adaptive study design in early phase research: The regulatory perspective Dr Martin O’Kane 11-12 April 2013 Slide 2 MHRA Family 2 Slide 3 Medicines & Healthcare…

Slide 1 Webinar Hosted by Pharmaceutical Manufacturing Wednesday, November 7 2012 Presented by Hedley Rees, Biotech PharmaFlow Slide 2 Agenda What is behind the ‘supply…

Slide 1 East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Regulatory Changes currently under consultation…

II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES OTHER ACTS Guidelines of 7 March 2013 on Good Distribution Practice of Medicinal…

Regulatory Changes currently under consultation Richard Bateman Quality Assurance Specialist Pharmacist Scope Consolidation and review of UK medicines legislation (MLX 375)…